"10.1371_journal.pone.0092869","plos one","2014-03-25T00:00:00Z","Oren Gordon; Zhiheng He; Dan Gilon; Sabine Gruener; Sherrie Pietranico-Cole; Amit Oppenheim; Eli Keshet","Departments of Developmental Biology and Cancer Research, The Hebrew University–Hadassah University Hospital, Jerusalem, Israel; Department of Cardiology, The Hebrew University–Hadassah University Hospital, Jerusalem, Israel; Department of Metabolic and Vascular Disease, Hoffmann-La Roche Pharmaceuticals, Basel, Switzerland","Conceived and designed the experiments: OG DG SG EK. Performed the experiments: OG ZH AO SPC. Analyzed the data: OG DG EK. Wrote the paper: OG EK.","This study was supported by Israel Science Foundation (ISF) and partly funded by Hoffmann-La Roche pharmaceuticals. Sabine Gruener, Sherrie Pietranico-Cole and Jacques Himber of Hoffmann-La Roche pharmaceuticals have contributed to the design and interpretation of some of the experiments detailed in this study, in particular for the novel 11HSD1 inhibitor. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2014","03","Oren Gordon","OG",7,TRUE,4,4,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
